R

Cartesian Therapeutics
D

RNAC

6.32000
USD
-0.26
(-3.95%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
2,243
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
191,213,825

العنوان: Cartesian Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.